Business of Biosimilars & Generic Drugs Session Spotlight: Think Different—Navigating the Brave New Globalized Life Science Industry

Steve Burrill is one of the most influential and trusted experts and advocates in the biotech industry, bringing over 40 years of experience with him. He has helped establish and grow many companies and stewarded the development of major strategic partnerships. This year at Business of Biosimilars & Generic Drugs, talk he will be discussing the new paradigm of organizational partnerships required for biosimilar development, approval, and commercialization, as well as how the industry must respond to regulatory change in order to grow.

For more information on Steve's presentation and the rest of  the 13th Annual Business of Biosimilars & Generic Drugs taking place September 12-14, 2012 in Boston, MA, download the agenda here.  As a reader of this blog, when you register to join us and mention code XP1786BLOG, you'll receive a discount of 25% off the standard rate.

Featured Session: Think Different—Navigating the Brave New Globalized Life Science Industry
Featured Speaker: G. Steven Burrill, CEO, BURRILL & COMPANY
About the session: G. Steven Burrill is one of the biotech industry’s greatest icons and advocates, with over 40 years of experience in guiding biotech firms towards greater growth, adaptability, and success. Now in the face of dramatic new regulatory changes and a shaky global economy, Mr. Burrill will help you focus on the key factors now impacting follow-on biologics and guide your company towards long-term staying power.

• • Strategic partnerships and acquisitions for biosimilar development: how big is this trend, and how can you take advantage if you aren’t already?
• • Healthcare reform in an election year: make sure that whoever loses in November, you win
• • Outlook and options for reimbursement amid economic uncertainty and global competition

Share this article with your social network, just click below to share now!

Share |